duit Pharmaceuticals (CDT) - 2023 Q2 - Quarterly Report

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes from the risk factors previously disclosed in our Annual Report for the year ended December 31, 2022, except as set forth below. Risks associated with the Merger and Conduit are more fully discussed in the Form S-4 that the Company has filed, as may be amended. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not p ...